|
|
||||||||
Vol. 84, Issue 1, 215-221, January 1998
-agonists
Pulmonary Research Laboratory, Department of Veterans Affairs Medical Center, Boise, Idaho 83702; and Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, Washington 98195
Carvalho, Paula, Shane R. Johnson, Nirmal B. Charan.
Non-cAMP-mediated bronchial arterial vasodilation in response to
inhaled
-agonists. J. Appl.
Physiol. 84(1): 215-221, 1998.
We studied the
dose-dependent effects of inhaled isoetharine HCl, a
-adrenergic
bronchodilator (2.5, 5.0, 10.0, and 20.0 mg), on bronchial blood flow
(
br) in anesthetized sheep. Isoetharine resulted in
a dose-dependent increase in
br. With a
total dose of 17.5 mg,
br increased from baseline
values of 22 ± 3.4 (SE) to 60 ± 16 ml/min
(P < 0.001), an effect independent
of changes in cardiac output and systemic arterial pressure. To further
study whether synthesis of endogenous nitric oxide (NO) affects
-agonist-induced increases in
br, we
administered isoetharine (20 mg) by inhalation before and after the
NO-synthase inhibitor
N
-nitro-L-arginine
methyl ester (L-NAME).
Intravenous L-NAME (30 mg/kg) rapidly decreased
br by ~80% of baseline,
whereas L-NAME via inhalation
(10 mg/kg) resulted in a delayed and smaller (~22%) decrease.
Pretreatment with L-NAME via
both routes of administration attenuated bronchial arterial
vasodilation after subsequent challenge with isoetharine. We conclude
that isoetharine via inhalation increases
br in a
dose-dependent manner and that
-agonist-induced relaxation of
vascular smooth muscle in the bronchial vasculature is partially
mediated via synthesis of NO.
bronchial circulation;
-adrenoreceptor agonists; nitric oxide; adenosine 3
,5
-cyclic monophosphate
This article has been cited by other articles:
![]() |
M. A. Norgaard, N. Alphonso, A. D. Cochrane, S. Menahem, C. P. Brizard, and Y. d'Udekem Major aorto-pulmonary collateral arteries of patients with pulmonary atresia and ventricular septal defect are dilated bronchial arteries. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 653 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Mendes, M. A. Campos, and A. Wanner Airway Blood Flow Reactivity in Healthy Smokers and in Ex-Smokers With or Without COPD. Chest, April 1, 2006; 129(4): 893 - 898. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Horvath and A. Wanner Inhaled corticosteroids: effects on the airway vasculature in bronchial asthma Eur. Respir. J., January 1, 2006; 27(1): 172 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Carvalho, W. H. Thompson, and N. B. Charan Comparative effects of alpha -receptor stimulation and nitrergic inhibition on bronchovascular tone J Appl Physiol, May 1, 2000; 88(5): 1685 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Norgaard, J. D. Hove, F. Efsen, K. Saunamaki, B. Hesse, and G. Pettersson Human bronchial artery blood flow after lung Tx with direct bronchial artery revascularization J Appl Physiol, September 1, 1999; 87(3): 1234 - 1239. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |